Episode 60 - Updates from AAAAI Conference 2023

Professors Marcus Maurer and Luis Felipe Ensina deliberate on the most recent findings that emerged at The American Academy of Allergy, Asthma & Immunology (AAAAI) conference held in San Antonio, Texas. In particular, Professor Maurer discusses poster presentations concerning the efficacious use of omalizumab and dupilumab for the management of urticaria. Professor Ensina expands the discussion by outlining ongoing projects and upcoming projects within UCARE that will be presented at the forthcoming UCARE conference in São Paulo in 2023.

Access additional resources by signing up to Medthority and to be notified for future 'All Things Urticaria' podcast episodes! 

Do you have suggestions for future episodes? Please visit UCARE to provide feedback via the link here and offer your suggestions for future topics and expert selection!